2021 CVM Updates
December
- December 21, 2021 - FDA Conditionally Approves First Oral Tablet to Treat Chemotherapy-Induced Diarrhea in Dogs
- December 20, 2021 - FDA Announces eSubmitter Update to Enhance Monitoring of Animal Drug Supply Chain
- December 17, 2021 - Department of Justice News - Prolific Thoroughbred Trainer Sentenced To Five Years In Federal Doping Case
- December 14, 2021 - FDA Releases Annual Summary Report on Antimicrobials Sold or Distributed in 2020 for Use in Food-Producing Animals
- December 3, 2021 - FDA Opens Second Grant Funding Application Period for FY2022 for Animal Drugs for Minor Uses and Minor Species
- December 2, 2021 - FDA Asks Reagan-Udall Foundation to Gather Stakeholder Feedback About Collection of Antimicrobial-Use Data in Food Animals
- December 1, 2021 - FDA Issues Final Rule for Laboratory Accreditation for Analyses of Foods
November
- November 22, 2021 - Department of Justice News - Court Enjoins California Company from Manufacturing and Distributing Adulterated Sterile Animal Drugs
October
- October 20, 2021 - FY 2019 Pesticide Report: Consistent with Trends Over the Past 8 Years, Pesticide Residue Levels Remain Low
- October 20, 2021 - Updated - FDA Announces Webinar on the Development of Animal Cells, Tissues, and Cell- and Tissue-based Products
- October 5, 2021 - Updated - FDA Issues Guidances to Help Facilitate the Development of New Animal Drug Submissions
- October 4, 2021 - FDA Announces Webinar on the Development of Animal Cells, Tissues, and Cell- and Tissue-based Products
September
- September 27, 2021 - FDA and United Kingdom Announce Mutual Recognition Agreement for Pharmaceutical Good Manufacturing Practice Inspections of Animal Drugs
- September 22, 2021 - FDA Issues Draft Guidance on Donor Eligibility and Manufacturing of Cellular Therapies for Animals
- September 10, 2021 - Department of Justice News - Owner Of Illegal Racehorse Doping Websites Sentenced To 18 Months In Prison
- September 7, 2021 - FDA to Participate in National Institutes of Health 2021 Pain in Animals Workshop
August
- August 27, 2021 - Resources for Animal Food Producers in the Gulf Coast of the United States Affected by Tropical Storm Ida (Español)
- August 19, 2021 - FDA Approves First Generic Amoxicillin and Clavulanate Potassium for Oral Suspension for Use in Cats and Dogs
- August 11, 2021 - FDA to Host Virtual Listening Session on the Oversight of Pet Food
July
- July 27, 2021 - FDA Announces FY 2022 Animal Drug User Fee Rates for ADUFA and AGDUFA
- July 15, 2021 - FDA Grants First Full Approval for Treatment of Lymphoma in Dogs
- July 15, 2021 - FDA Launches Resource to Increase Awareness of Animal Drug Safety-Related Labeling Changes
- July 13, 2021 - Updated - FDA Issues Final Guidance on Expanded Conditional Approval for Certain Animal Drugs
- July 6, 2021 - Resources for Animal Food Producers in the Southeastern United States Affected by Tropical Storm Elsa (Español)
June
- June 23, 2021 - FDA Requests Comment on Eligibility for Indexing of Unapproved Animal Drugs
- June 21, 2021 - Resources for Animal Food Producers in the Southeastern United States Affected by Tropical Storm Claudette (Español)
- June 10, 2021 - FDA Finalizes Guidance to Bring Remaining Approved Over-The-Counter Medically Important Antimicrobial Drugs Used for Animals Under Veterinary Oversight
- June 7, 2021 - FDA Explains Revised Submission Process for U.S. Animal Feed Additive, Premix, and Compound Feed Facilities Interested in Exporting to China
May
- May 28, 2021 - FDA Opens First Grant Funding Application Period for FY2022 for Animal Drugs for Minor Uses and Minor Species
- May 20, 2021 - Updated - FDA Issues Draft Guidance on Demonstrating Bioequivalence for Soluble Powder Animal Drugs
- May 12, 2021 - FDA Helps Improve Availability of Vetmedin, a Critical Heart Drug for Dogs, in the United States
- May 10, 2021 - FDA Announces Animal Biotechnology Stakeholder Virtual Outreach Session
- May 10, 2021 - FDA Opens Industry Portal for FSVP Records Submission
April
- April 23, 2021 - Department of Justice News - Owner Of Illegal Racehorse Doping Websites Pleads Guilty In Manhattan Federal Court
- April 13, 2021 - FDA Advises Companies Regarding Inadvertent Presence of Low Levels of Certain Genetically Engineered Canola Seeds
- April 9, 2021 - Updated - FDA Holds Virtual Public Meeting to Discuss Potential Approach for Ranking of Antimicrobial Drugs According to Their Importance in Human Medicine: A Risk Management Tool for Antimicrobial Animal Drugs
- April 6, 2021 - FDA Announces Improved Performance Measure Dashboards for Animal Drug and Food Key Initiatives
March
- March 30, 2021 - FDA Extends Flexibility for Unique Facility Identifier Requirement for Food Facility Registration through December 2022
- March 23, 2021 - FDA Approves First Generic Ketoprofen for Use in Horses
- March 9, 2021 - Department of Justice News - Operator of Racehorse Doping Websites Sentenced to 18 Months in Prison
February
- February 22, 2021 - Updated - FDA Seeks Public Comment on Potential Approach for Defining Durations of Use for Certain Medically Important Antimicrobial Drugs for Food Animals
- February 19, 2021 - FDA Approves First Generic Tulathromycin Products for Treating Disease in Certain Cattle and Swine
- February 8, 2021 - FDA Announces New Resource for Veterinarians and Pet Owners Interested in Clinical Field Studies of Animal Cells, Tissues, and Cell- and Tissue-Based Products
January
- January 15, 2021 - FDA Approves ThyroKare (levothyroxine sodium tablets) for Replacement Therapy for Diminished Thyroid Function in Dogs
- January 14, 2021 - FDA Grants First Conditional Approval Under Expanded Authority to Control Seizures in Dogs with Idiopathic Epilepsy
- January 11, 2021 - FDA Conditionally Approves First Oral Tablet to Treat Lymphoma in Dogs
- January 8, 2021 - FDA Seeks Public Comment on Potential Approach for Defining Durations of Use for Certain Medically Important Antimicrobial Drugs for Food Animals